Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model
We tested the hypothesis that Lipofectamine siRNA delivery to deplete transient receptor potential cation channel (TRPC) 1 protein expression can suppress hypoxia-induced pulmonary arterial hypertension (PAH) in mice. Adult male C57BL/6 mice were equally divided into group 1 (normal controls), grou...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2014/316214 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832567014178160640 |
---|---|
author | Cheuk-Kwan Sun Yen-Yi Zhen Hung-I Lu Pei-Hsun Sung Li-Teh Chang Tzu-Hsien Tsai Jiunn-Jye Sheu Yung-Lung Chen Sarah Chua Hsueh-Wen Chang Yi-Ling Chen Fan-Yen Lee Hon-Kan Yip |
author_facet | Cheuk-Kwan Sun Yen-Yi Zhen Hung-I Lu Pei-Hsun Sung Li-Teh Chang Tzu-Hsien Tsai Jiunn-Jye Sheu Yung-Lung Chen Sarah Chua Hsueh-Wen Chang Yi-Ling Chen Fan-Yen Lee Hon-Kan Yip |
author_sort | Cheuk-Kwan Sun |
collection | DOAJ |
description | We tested the hypothesis that Lipofectamine siRNA delivery to deplete transient receptor potential cation channel (TRPC) 1 protein expression can suppress hypoxia-induced pulmonary arterial hypertension (PAH) in mice. Adult male C57BL/6 mice were equally divided into group 1 (normal controls), group 2 (hypoxia), and group 3 (hypoxia + siRNA TRPC1). By day 28, right ventricular systolic pressure (RVSP), number of muscularized arteries, right ventricle (RV), and lung weights were increased in group 2 than in group 1 and reduced in group 3 compared with group 2. Pulmonary crowded score showed similar pattern, whereas number of alveolar sacs exhibited an opposite pattern compared to that of RVSP in all groups. Protein expressions of TRPCs, HIF-1α, Ku-70, apoptosis, and fibrosis and pulmonary mRNA expressions of inflammatory markers were similar pattern, whereas protein expressions of antifibrosis and VEGF were opposite to the pattern of RVSP. Cellular markers of pulmonary DNA damage, repair, and smooth muscle proliferation exhibited a pattern similar to that of RVSP. The mRNA expressions of proapoptotic and hypertrophy biomarkers displayed a similar pattern, whereas sarcomere length showed an opposite pattern compared to that of RVSP in all groups. Lipofectamine siRNA delivery effectively reduced TRPC1 expression, thereby attenuating PAH-associated RV and pulmonary arteriolar remodeling. |
format | Article |
id | doaj-art-c7ca4996bc854eadbcd9f20aaa29d5a2 |
institution | Kabale University |
issn | 1687-966X 1687-9678 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Stem Cells International |
spelling | doaj-art-c7ca4996bc854eadbcd9f20aaa29d5a22025-02-03T01:02:33ZengWileyStem Cells International1687-966X1687-96782014-01-01201410.1155/2014/316214316214Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine ModelCheuk-Kwan Sun0Yen-Yi Zhen1Hung-I Lu2Pei-Hsun Sung3Li-Teh Chang4Tzu-Hsien Tsai5Jiunn-Jye Sheu6Yung-Lung Chen7Sarah Chua8Hsueh-Wen Chang9Yi-Ling Chen10Fan-Yen Lee11Hon-Kan Yip12Department of Emergency Medicine, E-Da Hospital, I-Shou University College of Medicine, Kaohsiung 82445, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Thoracic and Cardiovascular Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanBasic Science, Nursing Department, Meiho Institute of Technology, Pingtung 91202, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Thoracic and Cardiovascular Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDepartment of Biological Sciences, National Sun Yat-sen University, Kaohsiung 80424, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Thoracic and Cardiovascular Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, TaiwanWe tested the hypothesis that Lipofectamine siRNA delivery to deplete transient receptor potential cation channel (TRPC) 1 protein expression can suppress hypoxia-induced pulmonary arterial hypertension (PAH) in mice. Adult male C57BL/6 mice were equally divided into group 1 (normal controls), group 2 (hypoxia), and group 3 (hypoxia + siRNA TRPC1). By day 28, right ventricular systolic pressure (RVSP), number of muscularized arteries, right ventricle (RV), and lung weights were increased in group 2 than in group 1 and reduced in group 3 compared with group 2. Pulmonary crowded score showed similar pattern, whereas number of alveolar sacs exhibited an opposite pattern compared to that of RVSP in all groups. Protein expressions of TRPCs, HIF-1α, Ku-70, apoptosis, and fibrosis and pulmonary mRNA expressions of inflammatory markers were similar pattern, whereas protein expressions of antifibrosis and VEGF were opposite to the pattern of RVSP. Cellular markers of pulmonary DNA damage, repair, and smooth muscle proliferation exhibited a pattern similar to that of RVSP. The mRNA expressions of proapoptotic and hypertrophy biomarkers displayed a similar pattern, whereas sarcomere length showed an opposite pattern compared to that of RVSP in all groups. Lipofectamine siRNA delivery effectively reduced TRPC1 expression, thereby attenuating PAH-associated RV and pulmonary arteriolar remodeling.http://dx.doi.org/10.1155/2014/316214 |
spellingShingle | Cheuk-Kwan Sun Yen-Yi Zhen Hung-I Lu Pei-Hsun Sung Li-Teh Chang Tzu-Hsien Tsai Jiunn-Jye Sheu Yung-Lung Chen Sarah Chua Hsueh-Wen Chang Yi-Ling Chen Fan-Yen Lee Hon-Kan Yip Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model Stem Cells International |
title | Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model |
title_full | Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model |
title_fullStr | Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model |
title_full_unstemmed | Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model |
title_short | Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model |
title_sort | reducing trpc1 expression through liposome mediated sirna delivery markedly attenuates hypoxia induced pulmonary arterial hypertension in a murine model |
url | http://dx.doi.org/10.1155/2014/316214 |
work_keys_str_mv | AT cheukkwansun reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT yenyizhen reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT hungilu reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT peihsunsung reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT litehchang reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT tzuhsientsai reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT jiunnjyesheu reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT yunglungchen reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT sarahchua reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT hsuehwenchang reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT yilingchen reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT fanyenlee reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel AT honkanyip reducingtrpc1expressionthroughliposomemediatedsirnadeliverymarkedlyattenuateshypoxiainducedpulmonaryarterialhypertensioninamurinemodel |